Eric d'Esparbes
2018 - Innoviva
In 2018, Eric d'Esparbes earned a total compensation of $2.8M as Former Senior Vice President and Chief Financial Officer at Innoviva, a 47% increase compared to previous year.
Compensation breakdown
| Salary | $280,217 |
|---|---|
| Stock Awards | $1,175,054 |
| Other | $1,371,443 |
| Total | $2,826,714 |
d'Esparbes received $1.4M in other compensation, accounting for 49% of the total pay in 2018.
d'Esparbes also received $280.2K in salary and $1.2M in stock awards.
Rankings
In 2018, Eric d'Esparbes' compensation ranked 4,120th out of 14,244 executives tracked by ExecPay. In other words, d'Esparbes earned more than 71.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,120 out of 14,244 | 71st |
Division Manufacturing | 1,515 out of 5,765 | 74th |
Major group Chemicals And Allied Products | 541 out of 2,128 | 75th |
Industry group Drugs | 451 out of 1,817 | 75th |
Industry Pharmaceutical Preparations | 348 out of 1,391 | 75th |
Source: SEC filing on March 13, 2019.
d'Esparbes' colleagues
We found five more compensation records of executives who worked with Eric d'Esparbes at Innoviva in 2018.
2018
Michael Aguiar
Innoviva
Chief Executive Officer
2018
George Abercrombie
Innoviva
Former Senior Vice President and Chief Commercial Officer
2018
Theodore Witek
Innoviva
Chief Scientific Officer
2018
Marianne Zhen
Innoviva
Chief Accounting Officer
2018
Geoffrey Hulme
Innoviva
Interim Principal Executive Officer
News
BIORA THERAPEUTICS CEO Adi Mohanty's 2023 pay slips 11% to $3.1M
April 24, 2024
BIORA THERAPEUTICS CEO Adi Mohanty's 2022 pay falls 65% to $3.5M
April 27, 2023
BIORA THERAPEUTICS CEO Adi Mohanty receives $10M in 2021
April 28, 2022
BIORA THERAPEUTICS CEO Harry Stylli's 2020 pay jumps 1,357% to $5.8M
April 15, 2021
Innoviva CEO Michael Aguiar's 2018 pay slips 11% to $3.7M
March 13, 2019